RxDoctor Payments Data

Angeline Heaver

Nurse Practitioner · Elgin, ILNPI 1053688275

Payments from drug & device makers

$1,224in general payments, 2019–2025

Across 40 payments — averaging $30.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$297
  • Abbott$162
  • Edwards Lifesciences$145
  • Johnson & Johnson$105
  • Boston Scientific$90
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$68
  • plus $357 from 11 others

What the payments were for

  • Food & beverage$1,20899%
  • Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,224 in reported general payments places this provider in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$62,135
Medicare patients
321
Services billed
1,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban91$101,954
XareltoRivaroxaban29$42,964
Metolazone39$2,051
Potassium Chloride94$1,982
Metoprolol Succinate112$1,605
Midodrine Hcl18$1,402
Losartan Potassium103$1,202
Amlodipine Besylate118$1,152
Furosemide208$1,141
Atorvastatin Calcium123$1,056
Hydralazine Hcl40$1,004
Bumetanide23$913
Metoprolol Tartrate94$825
Valsartan11$693
Rosuvastatin Calcium40$623

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$101,95491 claims
Johnson & JohnsonXarelto$105$42,96429 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Elgin

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →